4.7 Article

Cytokine storm in severe COVID-19 pneumonia

Related references

Note: Only part of the references are listed.
Article Immunology

Assessment of the Hemophagocytic Lymphohistiocytosis HScore in Patients With Coronavirus Disease 2019

Kristina E. N. Clark et al.

Summary: This study found similarities in the clinical manifestations and molecular inflammatory responses between COVID-19 patients and HLH patients, but did not support the use of HLH risk-scoring methodology for risk stratification in COVID-19 patients.

CLINICAL INFECTIOUS DISEASES (2021)

Article Medicine, General & Internal

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Dawei Wang et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Critical Care Medicine

Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan A Retrospective Observational Study

Yingzhen Du et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Article Rheumatology

Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets

Durga Prasanna Misra et al.

CLINICAL RHEUMATOLOGY (2020)

Article Multidisciplinary Sciences

Effective treatment of severe COVID-19 patients with tocilizumab

Xiaoling Xu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Letter Medicine, General & Internal

COVID-19: consider cytokine storm syndromes and immunosuppression

Puja Mehta et al.

LANCET (2020)

Article Hematology

Changes of hematological and immunological parameters in COVID-19 patients

Xiaohong Yuan et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2020)

Article Virology

Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China

Guqin Zhang et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

Article Rheumatology

Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study

Brandon J. Webb et al.

LANCET RHEUMATOLOGY (2020)

Review Rheumatology

Macrophage activation syndrome

A Ravelli

CURRENT OPINION IN RHEUMATOLOGY (2002)